AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LETROZOLE
87 registrations across 15 African markets— 67 active
Markets with LETROZOLE
🇺🇬Uganda
16 registrations
16 active
🇿🇦South Africa
14 registrations
11 active
🇹🇳Tunisia
11 registrations
0 active
🇨🇮Côte d'Ivoire
8 registrations
3 active
🇳🇬Nigeria
6 registrations
6 active
🇬🇭Ghana
6 registrations
6 active
🇿🇼Zimbabwe
5 registrations
5 active
🇲🇦Morocco
5 registrations
5 active
🇲🇬Madagascar
4 registrations
4 active
🇹🇿Tanzania
3 registrations
3 active
🇸🇳Senegal
3 registrations
3 active
🇷🇼Rwanda
2 registrations
2 active
🇰🇪Kenya
2 registrations
2 active
🇲🇼Malawi
1 registration
0 active
🇿🇲Zambia
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| FEMARA TABLETS (Each Film-coated Tablet contains Letrozole 2.5mg) | 🇬🇭Ghana | — | active | Aug 2031 |
| FEMARA TABLETS (Each Film-coated Tablet contains Letrozole 2.5mg) | 🇬🇭Ghana | — | active | Aug 2031 |
| LETROZOLE DENK TABLETS (Each film coated tablet contains Letrozole 2.5mg) | 🇬🇭Ghana | — | active | Jul 2031 |
| LETROZOLE DENK TABLETS (Each film coated tablet contains Letrozole 2.5mg) | 🇬🇭Ghana | — | active | Jul 2031 |
| Femara 2.5 Tablets Film Coated Tablets | 🇿🇲Zambia | Novartis Pharma Services | active | Jun 2030 |
| TREXOZOLA TABLETS | 🇷🇼Rwanda | TECHNO PHARMA EGYPT | active | Feb 2030 |
| Letromine 2.5 mg Tablet** Tablet | 🇳🇬Nigeria | Carrot-Top Drugs Ltd | active | Sept 2029 |
| LETERO TABLETS | 🇷🇼Rwanda | M/S. Hetero Labs Limited (Unit-VI) | active | Aug 2029 |
| LETERO TABLETS TABLETS (Each tablet contains Letrozole 2.5mg) | 🇬🇭Ghana | — | active | Aug 2029 |
| LETERO TABLETS TABLETS (Each tablet contains Letrozole 2.5mg) | 🇬🇭Ghana | — | active | Aug 2029 |
| Xylox 2.5 Tablet** Tablet | 🇳🇬Nigeria | AnnyGod Pharmaceutical Company Ltd | active | Feb 2029 |
| Letrozole USP 2.5 mg** Tablet | 🇳🇬Nigeria | Hetero Labs Nigeria Limited | active | Dec 2028 |
| FEMPRO TABLET, COATED; ORAL | 🇿🇼Zimbabwe | CIPLA LTD | active | Aug 2028 |
| Letrozole 2.5mg Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2028 |
| LETROZOLE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | NOVARTIS SOUTH AFRICA (PTY) LTD | active | Dec 2027 |
| LETERO TABLET, COATED; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Dec 2027 |
| LETRASAN TABLET, COATED; ORAL | 🇿🇼Zimbabwe | KEY ONCOLOGICS (PYT) LTD | active | Dec 2027 |
| FEMARA TABLET, COATED; ORAL | 🇿🇼Zimbabwe | NOVARTIS PHARMA SERVICES AG | active | Dec 2027 |
| LETRODAY 2.5 Film-Coated Tablet | 🇰🇪Kenya | Aurobindo Pharma Limited | active | Oct 2027 |
| FERTIZOL TABLETS Film-Coated Tablet | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LIMITED | active | Sept 2027 |
| Glotraz Tablet** Tablet | 🇳🇬Nigeria | Uche St. Pharmaceutical Company Limited | active | Aug 2026 |
| Femara Film Coated Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Dec 2025 |
| LETROZOLE ADCO 2,5 | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Aug 2025 |
| MEDPRO LETROZOLE 2,5 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| LESPER 2,5MG COMPRIME BOITE DE 10 | 🇨🇮Côte d'Ivoire | MEDNEXT BIOTECH LIMITED | expired | Oct 2024 |
| LETROVIN 2,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | ZEE LABORATORIES LIMITED | expired | Oct 2024 |
| LETS 2,5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | GENIX PHARMA PVT LTD | expired | Feb 2024 |
| ZETRA | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | suspended | Dec 2023 |
| LETERO 2,5MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | HETERO LABS LIMITED | expired | Jan 2023 |
| LETROZOLE NOVARTIS ACCES 2,5MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jan 2023 |
| LETROZOLE PHARMACARE Comprimé / 2.5 mg | 🇹🇳Tunisia | PHARMACARE PREMIUM LIMITED | expired | Jun 2022 |
| LETROZOLE ADVANS Comprimé pelliculé / 2.5mg | 🇹🇳Tunisia | ADVANS PHARMA | expired | Sept 2020 |
| LETERO 2.5MG TABLETS TABLETS | 🇲🇼Malawi | — | expired | Jun 2020 |
| LETROZOLE NEAPOLIS Comprimé pelliculé / 2.5 mg | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Aug 2019 |
| LETROZOLE ACCORD Comprimé pelliculé / 2.5 mg | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Jul 2019 |
| LETROZOLE VIATRIS Comprimé pelliculé / 2.5 mg | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jun 2018 |
| GYNOTRIL Comprimé pelliculé / 2.5 mg | 🇹🇳Tunisia | ERIS PHARMACEUTICALS PTY LTD | expired | Jun 2016 |
| LETROZOLE KERN PHARMA Comprimé pelliculé / 2.5 mg | 🇹🇳Tunisia | KERN PHARMA SL | expired | Jul 2015 |
| FEMAPLEX Comprimé pelliculé / 2.5 mg | 🇹🇳Tunisia | GENEPHARM S.A | expired | May 2015 |
| LEFFTARA Comprimé pelliculé / 2.5 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Feb 2014 |
| LETROZOLE ACTAVIS Comprimé pelliculé / 2.5 mg | 🇹🇳Tunisia | ACTAVIS Group PTC ehf | expired | Apr 2013 |
| FEMARA Comprimé pelliculé / 2.5 mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Apr 2006 |
| LETRAZ | 🇿🇦South Africa | Equity Pharmaceutical (Pty) Ltd | active | Jan 1900 |
| FEMZOLE 2,5 | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| ACCORD-LETROZOLE 2,5 mg | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| LARADEX | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jan 1900 |
| ROZARA | 🇿🇦South Africa | Ascendis Pharma (Pty) Ltd | active | Jan 1900 |
| ROZILAT | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Jan 1900 |
| FAZALET | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Jan 1900 |
| CIPLA LETROZOLE 2,5 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
Showing 50 of 87 registrations. Sign up free to search and export all.
LETROZOLE in Africa — Regulatory Overview
LETROZOLE is registered across 15 African markets with 87 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, South Africa, Tunisia, Côte d'Ivoire and 11 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 87 registrations, 67 (77%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.